vs
Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
NexPoint Real Estate Finance, Inc. is the larger business by last-quarter revenue ($11.1M vs $8.6M, roughly 1.3× Sunshine Biopharma Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -25.0%, a 241.6% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -48.8%).
NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
NREF vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $8.6M |
| Net Profit | $24.0M | $-2.1M |
| Gross Margin | — | 35.3% |
| Operating Margin | — | -20.9% |
| Net Margin | 216.6% | -25.0% |
| Revenue YoY | -48.8% | -10.6% |
| Net Profit YoY | 58.7% | 0.8% |
| EPS (diluted) | $0.47 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $8.6M | ||
| Q3 25 | $12.5M | $9.4M | ||
| Q2 25 | $12.1M | $9.4M | ||
| Q1 25 | $11.5M | $8.9M | ||
| Q4 24 | $21.7M | $9.6M | ||
| Q3 24 | $12.5M | $8.4M | ||
| Q2 24 | $6.7M | $9.3M | ||
| Q1 24 | $-12.8M | $7.5M |
| Q4 25 | $24.0M | $-2.1M | ||
| Q3 25 | $50.9M | $-883.8K | ||
| Q2 25 | $22.3M | $-1.8M | ||
| Q1 25 | $26.0M | $-1.2M | ||
| Q4 24 | $15.2M | $-2.2M | ||
| Q3 24 | $23.3M | $-1.2M | ||
| Q2 24 | $12.1M | $-494.3K | ||
| Q1 24 | $-14.6M | $-1.3M |
| Q4 25 | — | 35.3% | ||
| Q3 25 | — | 32.6% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 32.2% | ||
| Q3 24 | — | 34.0% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 31.2% |
| Q4 25 | — | -20.9% | ||
| Q3 25 | — | -11.5% | ||
| Q2 25 | — | -21.8% | ||
| Q1 25 | — | -14.6% | ||
| Q4 24 | — | -21.7% | ||
| Q3 24 | — | -13.1% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -17.9% |
| Q4 25 | 216.6% | -25.0% | ||
| Q3 25 | 407.0% | -9.4% | ||
| Q2 25 | 184.5% | -18.8% | ||
| Q1 25 | 225.6% | -13.3% | ||
| Q4 24 | 69.9% | -22.5% | ||
| Q3 24 | 186.4% | -14.2% | ||
| Q2 24 | 179.7% | -5.3% | ||
| Q1 24 | 114.3% | -17.0% |
| Q4 25 | $0.47 | — | ||
| Q3 25 | $1.14 | $-0.54 | ||
| Q2 25 | $0.54 | $-0.82 | ||
| Q1 25 | $0.70 | $-0.44 | ||
| Q4 24 | $0.71 | $49.77 | ||
| Q3 24 | $0.74 | $-11.61 | ||
| Q2 24 | $0.40 | $-43.48 | ||
| Q1 24 | $-0.83 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.1M | — |
| Total DebtLower is stronger | $771.2M | — |
| Stockholders' EquityBook value | $388.0M | $23.0M |
| Total Assets | $5.3B | $30.1M |
| Debt / EquityLower = less leverage | 1.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $19.2M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $34.7M | — | ||
| Q2 24 | $4.3M | — | ||
| Q1 24 | $13.5M | — |
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
| Q4 25 | $388.0M | $23.0M | ||
| Q3 25 | $375.4M | $24.2M | ||
| Q2 25 | $348.2M | $25.7M | ||
| Q1 25 | $343.7M | $22.7M | ||
| Q4 24 | $336.5M | $23.5M | ||
| Q3 24 | $335.8M | $25.0M | ||
| Q2 24 | $327.5M | $23.5M | ||
| Q1 24 | $327.1M | $24.8M |
| Q4 25 | $5.3B | $30.1M | ||
| Q3 25 | $5.3B | $31.5M | ||
| Q2 25 | $5.4B | $32.0M | ||
| Q1 25 | $5.4B | $29.2M | ||
| Q4 24 | $5.4B | $30.6M | ||
| Q3 24 | $5.7B | $30.1M | ||
| Q2 24 | $6.6B | $29.3M | ||
| Q1 24 | $7.1B | $31.9M |
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.5M | $-1.6M |
| Free Cash FlowOCF − Capex | — | $-1.6M |
| FCF MarginFCF / Revenue | — | -18.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.5M | $-1.6M | ||
| Q3 25 | $8.1M | $-727.8K | ||
| Q2 25 | $3.3M | $-1.3M | ||
| Q1 25 | $16.0M | $-1.7M | ||
| Q4 24 | $4.4M | $-3.4M | ||
| Q3 24 | $14.7M | $-1.4M | ||
| Q2 24 | $-7.5M | $-4.6M | ||
| Q1 24 | $17.7M | $-3.2M |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $-735.8K | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | -18.9% | ||
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | -15.2% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | — | -22.2% | ||
| Q2 24 | — | -59.7% | ||
| Q1 24 | — | -43.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
